Join
Live feed
·
INSIDERFilingvia Quantisnow
BioMarin Pharmaceutical Inc. logo

Director Enyedy Mark J was granted 7,490 shares, increasing direct ownership by 55% to 21,040 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
BMRN· BioMarin Pharmaceutical Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BMRN (BioMarin Pharmaceutical Inc.) and more on Quantisnow.